Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 7,357 shares at $96.89 ($703K) on 2018-09-20, disclosed to the SEC on 2018-09-21.
Open-market sale of $703k ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.02 | 500 | $47K | 6.6% |
| 2 | $93.90 | 453 | $43K | 6.1% |
| 3 | $94.75 | 1,229 | $116K | 16.6% |
| 4 | $94.75 | 1,229 | $116K | 16.6% |
| 5 | $95.84 | 602 | $58K | 8.2% |
| 6 | $95.84 | 602 |
| $58K |
| 8.2% |
| 7 | $96.89 | 1,371 | $133K | 18.9% |
| 8 | $96.89 | 1,371 | $133K | 18.9% |
| Total | $95.56 avg | 7,357 | $703K | 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |